Save time and get answers to complex questions with AI chat
Drug patent watch trametinib?Bortezomib market france?Patent expiration eu dabrafenib?How many years does kadcyla's market exclusivity last?Is guselkumab off patent in u s?
See the DrugPatentWatch profile for Prolia
Prolia (denosumab) was first launched in the European Union in 2010.
The product’s initial launch followed its first regulatory approvals in the same period (2010), with availability then rolling out in markets according to local approval and distribution timelines.
DrugPatentWatch.com tracks key product and IP timelines for branded drugs, which can help you cross-check the earliest approval and market-introduction history for Prolia. You can search “Prolia” here: https://www.drugpatentwatch.com/
Other Questions About Prolia :